1. Home
  2. SHIM vs EQ Comparison

SHIM vs EQ Comparison

Compare SHIM & EQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shimmick Corporation

SHIM

Shimmick Corporation

HOLD

Current Price

$3.21

Market Cap

160.8M

Sector

N/A

ML Signal

HOLD

Logo Equillium Inc.

EQ

Equillium Inc.

HOLD

Current Price

$1.67

Market Cap

140.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SHIM
EQ
Founded
1990
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
160.8M
140.1M
IPO Year
2023
2018

Fundamental Metrics

Financial Performance
Metric
SHIM
EQ
Price
$3.21
$1.67
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
★ $8.00
AVG Volume (30 Days)
161.9K
★ 515.0K
Earning Date
05-14-2026
05-25-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 81.95
N/A
EPS
N/A
★ N/A
Revenue
★ $492,844,000.00
$41,095,000.00
Revenue This Year
$13.99
N/A
Revenue Next Year
$6.94
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 2.63
N/A
52 Week Low
$1.95
$0.76
52 Week High
$6.76
$3.54

Technical Indicators

Market Signals
Indicator
SHIM
EQ
Relative Strength Index (RSI) 38.21 32.24
Support Level $2.49 $1.05
Resistance Level $4.09 $1.71
Average True Range (ATR) 0.20 0.18
MACD -0.01 -0.04
Stochastic Oscillator 6.47 1.44

Price Performance

Historical Comparison
SHIM
EQ

About SHIM Shimmick Corporation

Shimmick Corp is engaged in delivering turnkey infrastructure solutions that strengthen critical markets across water, energy, climate resiliency, and sustainable transportation. It selectively focuses on the following types of infrastructure projects: Water Treatment, Water Resources, and Other Critical Infrastructure. In water treatment projects the company expands, rehabilitates, upgrades, builds and rebuilds water and wastewater treatment infrastructure. In Other Critical Infrastructure projects, It builds, retrofits, expands, rehabilitates, operates, and maintains critical infrastructure, including mass transit, bridges, and military infrastructure. The company has one operating and reportable segment: infrastructure solutions. All of its revenue is derived from the United States.

About EQ Equillium Inc.

Equillium Inc is a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders with the mission to develop life-changing therapeutics for patients. It primary goal is to advance EQ504, a novel aryl hydrocarbon receptor, or AhR, modulator, into and through clinical development. The Company operates through a single operating and reportable segment focused on the business of developing novel therapies to treat severe autoimmune and inflammatory disorders, with the mission to develop life-changing therapeutics for patients. The Company manages all business activities on a consolidated basis.

Share on Social Networks: